These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28486001)

  • 41. Antimicrobial resistance among gram-negative foodborne bacterial pathogens associated with foods of animal origin.
    White DG; Zhao S; Singh R; McDermott PF
    Foodborne Pathog Dis; 2004; 1(3):137-52. PubMed ID: 15992273
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
    Kasiakou SK; Michalopoulos A; Soteriades ES; Samonis G; Sermaides GJ; Falagas ME
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3136-46. PubMed ID: 16048915
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cefiderocol: a novel siderophore cephalosporin.
    Choi JJ; McCarthy MW
    Expert Opin Investig Drugs; 2018 Feb; 27(2):193-197. PubMed ID: 29318906
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09).
    Gales AC; Jones RN; Sader HS
    J Antimicrob Chemother; 2011 Sep; 66(9):2070-4. PubMed ID: 21715434
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacodynamics of cefepime in patients with Gram-negative infections.
    Tam VH; McKinnon PS; Akins RL; Rybak MJ; Drusano GL
    J Antimicrob Chemother; 2002 Sep; 50(3):425-8. PubMed ID: 12205070
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro activity of 'old antibiotics' against highly resistant Gram-negative bacteria.
    Dubourg G; Okdah L; Le Page S; Rolain JM; Raoult D
    Int J Antimicrob Agents; 2015 Dec; 46(6):718-20. PubMed ID: 26589488
    [No Abstract]   [Full Text] [Related]  

  • 47. Correlation between antibiotic consumption and resistance of Gram-negative bacteria causing healthcare-associated infections at a university hospital in Taiwan from 2000 to 2009.
    Lai CC; Wang CY; Chu CC; Tan CK; Lu CL; Lee YC; Huang YT; Lee PI; Hsueh PR
    J Antimicrob Chemother; 2011 Jun; 66(6):1374-82. PubMed ID: 21436153
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Editorial: Resistance in gram-negative pathogens: a threat to global health.
    Hanson ND
    Curr Pharm Des; 2013; 19(2):163. PubMed ID: 22920832
    [No Abstract]   [Full Text] [Related]  

  • 49. Antibiotic resistance. Nosocomial gram-negative infection.
    Gransden WR
    J Med Microbiol; 1997 Jun; 46(6):436-9. PubMed ID: 9379467
    [No Abstract]   [Full Text] [Related]  

  • 50. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
    Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
    Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cephalosporins currently in early clinical trials for the treatment of bacterial infections.
    Long TE; Williams JT
    Expert Opin Investig Drugs; 2014 Oct; 23(10):1375-87. PubMed ID: 24956017
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Distribution of plasmid-mediated quinolone resistance in Gram-negative bacteria from a tertiary hospital in Nigeria.
    Ogbolu DO; Alli AO; Anorue MC; Daini OA; Oluwadun A
    Indian J Pathol Microbiol; 2016; 59(3):322-6. PubMed ID: 27510669
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review.
    Zavascki AP; Goldani LZ; Li J; Nation RL
    J Antimicrob Chemother; 2007 Dec; 60(6):1206-15. PubMed ID: 17878146
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An overview of antimicrobial susceptibility patterns for gram-negative bacteria from the National Antimicrobial Resistance Surveillance Thailand (NARST) program from 2000 to 2005.
    Apisarnthanarak A; Buppunharun W; Tiengrim S; Sawanpanyalert P; Aswapokee N
    J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S91-4. PubMed ID: 21298849
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mastering the Gram-negative bacterial barrier - Chemical approaches to increase bacterial bioavailability of antibiotics.
    Ropponen HK; Richter R; Hirsch AKH; Lehr CM
    Adv Drug Deliv Rev; 2021 May; 172():339-360. PubMed ID: 33705882
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Do We Bury Antibacterials When Launching? Cefaclor Example.
    Tomić Z; Tomas A; Vukmirović S; Mikov M; Horvat O; Tomić N; Sabo A
    J Pharm Sci; 2016 Mar; 105(3):1295-300. PubMed ID: 26886327
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antibiotic rotation and development of gram-negative antibiotic resistance.
    van Loon HJ; Vriens MR; Fluit AC; Troelstra A; van der Werken C; Verhoef J; Bonten MJ
    Am J Respir Crit Care Med; 2005 Mar; 171(5):480-7. PubMed ID: 15516540
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increasing extended-spectrum beta-lactamase production and quinolone resistance among Gram-negative bacilli causing intra-abdominal infections in the Asia/Pacific region: data from the Smart Study 2002-2006.
    Ko WC; Hsueh PR
    J Infect; 2009 Aug; 59(2):95-103. PubMed ID: 19564044
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The current state of multidrug-resistant gram-negative bacilli in North America.
    Nicasio AM; Kuti JL; Nicolau DP
    Pharmacotherapy; 2008 Feb; 28(2):235-49. PubMed ID: 18225969
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential correlation between rates of antimicrobial drug consumption and prevalence of antimicrobial resistance in a tertiary care hospital in Greece.
    Iosifidis E; Antachopoulos C; Tsivitanidou M; Katragkou A; Farmaki E; Tsiakou M; Kyriazi T; Sofianou D; Roilides E
    Infect Control Hosp Epidemiol; 2008 Jul; 29(7):615-22. PubMed ID: 18624668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.